ICD-10-CM Billable Code

C84.Z4

Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code C84.Z4 refers to a category of rare blood cancers known as other mature T-cell and natural killer (NK) cell lymphomas, specifically affecting lymph nodes in the axilla (armpit) and upper limb. These lymphomas originate from T-cells and NK-cells, which are types of white blood cells that play vital roles in immune response. Although they are less common than B-cell lymphomas, these diseases require specialized medical attention due to their unique behavior and treatment approaches.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting T-cell or NK-cell development Previous exposure to certain chemicals or toxins Chronic immune system stimulation or infection Immunosuppressive therapy or conditions impairing immune surveillance Unknown factors; in many cases, the exact cause remains unidentified

Key Symptoms: Painless swelling or enlarged lymph nodes in the axilla and upper limb Unexplained weight loss Persistent fever Night sweats Fatigue and weakness Itching or skin changes near the affected area Possible pain or discomfort in the swollen lymph node regions

Diagnostic & Treatment

Diagnosis Path: Diagnosing this type of lymphoma involves multiple steps. Physicians typically conduct a physical examination to identify enlarged lymph nodes and assess other symptoms. Confirmatory diagnosis requires laboratory tests and procedures including: - Blood tests to evaluate blood cell counts and organ function - Imaging studies such as CT scans or PET scans to visualize lymph node involvement and spread - Lymph node biopsy, which involves removing a tissue sample for microscopic examination to identify the characteristic cancer cells - Immunophenotyping tests to determine cell types and markers - Molecular studies may also be performed to detect genetic abnormalities associated with the lymphoma The combination of these evaluations helps establish an accurate diagnosis and determine the disease's extent and stage.

Treatment Protocols: Treatment strategies for other mature T/NK-cell lymphomas in the axilla and upper limb often involve a combination of therapies tailored to the individual patient. Common approaches include: - Chemotherapy: Using drug regimens to attack cancer cells broadly. - Radiation therapy: Targeted radiation to eliminate residual disease in affected lymph nodes. - Immunotherapy: Employing agents that enhance the immune response against lymphoma cells. - Targeted therapy: Drugs designed to interact with specific molecular targets associated with the cancer. - Stem cell transplantation: Considered for advanced cases or in remission to consolidate treatment benefits. Patients' treatment plans are individualized based on factors such as age, overall health, disease stage, and response to initial treatments. These therapies are usually managed in specialized centers due to the complexity of the disease.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C84.Z4 a billable ICD-10 code?
Yes, C84.Z4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C84.Z4?
Clinical documentation must specify the nature of Other mature T/NK-cell lymphomas, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.

Cite this Clinical Reference